top of page
Regulatory news and experts insights.
Stay updated with the latest developments, guidance, and resources in chemical regulations.
Search


EFSA opinion on berberine, protoberberines, and plants containing these substances : understanding the draft to engage in the dialogue.
In January 2026, the European Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods, and Food Allergens (NDA) endorsed a draft opinion on the safety of plant preparations containing berberine.
Apr 18 min read


PFAS in Drinking Water: Technical Analysis of a New Regulatory Era for Water Utilities
Since 12 January 2026, the European Union has reached a major milestone in the protection of public health and water resources. The transition period provided for under Directive (EU) 2020/2184 (recast Drinking Water Directive) has now ended.
Feb 254 min read


On the Assessment of the Reproductive or Teratogenic Potential of Cosmetic Ingredients
The use of any new cosmetic ingredient must be safe. That is a legal obligation according to Article 3 of the European Cosmetic Regulation and in other cosmetic-related laws and standards throughout the world, but also a moral one, as it would be unethical to place on the market a substance that is toxic, or whose toxicity is unknown and for which safe exposure cannot be demonstrated.
Jan 285 min read


Directive (EU) 2020/2184: Revision of Drinking Water Quality Standards in EU
The Directive (EU) 2020/2184, adopted on December 16, 2020, marks a pivotal change in the management of drinking water across EU. It replaces the 1998 directive and aims to ensure universal access to safe and high-quality drinking water while enhancing transparency, monitoring, and risk management. This legislation has significant implications for water suppliers, industries dealing with materials in contact with water, as well as consultants and other stakeholders in the sec
Nov 19, 20256 min read


The Era of N-Nitrosamines in the Pharmaceutical Industry – A Comprehensive Toxicological Perspective
L'apparition inattendue d'impuretés de N-nitrosamines dans les médicaments a marqué un tournant réglementaire majeur. Ces composés, connus dans l'environnement et l'alimentation, ont forcé l'industrie pharmaceutique mondiale à revoir ses processus. Face à cette situation, une coordination internationale sans précédent a vu le jour entre les agences réglementaires mondiales, telles que la FDA (États-Unis),
Nov 5, 20254 min read
bottom of page
